Prescription Drug Abuse and Diversion Training Conference

July 23, 2021

The objective of this course is to provide further education and knowledge of the Pennsylvania drug laws related to the medical field, safety with fentanyl and naloxone, preventing institutional drug diversion, an expert perspective on opioid prescribing, and current drug trends, specifically opioids.

Target Audience

The target audience for this training includes medical professionals, first responders, law enforcement and compliance investigators. 

Course summary
Available credit: 
  • 6.75 ACPE Pharmacy
    The UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
  • 6.75 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 6.75 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 6.75 Attendance
Course opens: 
04/22/2021
Course expires: 
12/31/2021
Event starts: 
07/23/2021 - 8:30am
Event ends: 
07/23/2021 - 4:30pm

Agenda

7:30 AM - 8:30 AM                Registration - Coffee Service

8:30 AM - 8:45 AM                Opening Remarks

Charlie Cichon, NADDI Executive Director

Matt Massaro, NADDI PA State Chapter President

8:45 AM - 9:40 AM                Prescription Drug Laws, Prevention of Diversion and Case Study

Matt Massaro, NADDI PA Chapter President

Pennsylvania Attorney General Narcotics Agent

9:40 AM                                  Break

9:50 AM - 10:50 AM             Drug Abuse During COVID-19

Dr. Matthew Bouchard

10:50 AM                                Break

11:00 AM - 12:15 PM            Real Life Story of Addiction and the Impact on the Family of a Law

Enforcement Officer

Kevin Simmers, Former Maryland Narcotics Officer

12:15 PM - 1:00 PM               Boxed Lunch – Provided by NADDI

1:00 PM - 2:00 PM                 Controlled Substances Investigations: A Physician’s Perspective

Stephen M. Thomas, MD

2:00 PM                                  Break

2:15 PM - 3:15 PM                 Rx Diversion: Opioid Abuse – The Scope of the Problem

Dan Zsido, NADDI National Director Education and Training

3:15 PM                                  Break

3:30PM - 4:30 PM                  Preventing and Investigating Institutional Diversion

Edward Cartwright

PA Office of the Attorney General (Retired)

4:30 PM                                  Closing Remarks

Matt Massaro

5:00 PM                                  Adjournment

Blair County Convention Center
Altoona, PA 16602
United States

Faculty listing 

Sherri O’Donald, Controlled Substance Compliance Manager, PA NADDI Vice President, Altoona, PA

Matthew Massaro, Narcotics Agent, PA Office of Attorney General, State College, PA

Edward Cartwright, Retired Narcotics Agent, PA Office of Attorney General, North Huntingdon, PA

Kevin Simmers, Retired Police Officer Hagerstown, MD

Matthew Bouchard, Chairman of Emergency Medicine, UPMC Altoona, Altoona, PA

Stephen Thomas, Medical Expert, Pittsburgh, PA

Dan Zsido, NADDI National Education and Training Director, Seminole, Florida

Faculty Disclosure:
All individuals in a position to control the content of this education activity including members of the planning committee, speakers, presenters, authors, and/or content reviewers have disclosed  all relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients.

The following relevant financial relationships were disclosed:
•    Edward Cartwright is an employee of Value Drug Company.

No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

In support of improving patient care, this activity has been planned and implemented by the University of Pittsburgh and National Association of Drug Diversion Investigators (NADDI). The University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 6.75 contact hours.

Pharmacy (CPE)
This knowledge-based activity provides 6.75 contact hours of continuing pharmacy education credit. 

Other Healthcare Professionals
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Available Credit

  • 6.75 ACPE Pharmacy
    The UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
  • 6.75 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 6.75 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 6.75 Attendance
Please login or register to take this course.

Conference Registration Information

Registration will be completed online

at
2021 NADDI Pennsylvania Regional Training Conference - NADDI - National Association of Drug Diversion Investigators

Participation by all individuals is encouraged. Advance notification of any special needs will help us provide better service. Please notify us of your needs at least two weeks in advance of the program by calling 814-889-2226.

The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine.  Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.